Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
06/28/2007 | US20070148663 recombinant nucleic acid which when introduced in vivo into a mammalian cell endogenously expressing EB1, inhibits the expression of EB1 therein, thereby reducing the amount of stable microtubules in the cell; antinflammatory agents |
06/28/2007 | US20070148662 Prostate-specific membrane antigen |
06/28/2007 | US20070148655 Leucine rich repeat containing protein |
06/28/2007 | US20070148287 Cgtase variants |
06/28/2007 | US20070148201 Muteins of a bilin-binding protein with affinity for a given target |
06/28/2007 | US20070148184 Survivin-derived peptides and use thereof |
06/28/2007 | US20070148180 Peptide-immunoglobulin-conjugate |
06/28/2007 | US20070148179 Gankyrin |
06/28/2007 | US20070148176 Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
06/28/2007 | US20070148173 Treatment of Acute Lung Injury, Fibrosis and Metastasis with Antagonists of Alpha V Beta 6 |
06/28/2007 | US20070148166 Scfvs in photosynthetic microbes |
06/28/2007 | US20070148164 Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto |
06/28/2007 | US20070148163 Mutants of anti-cd40 antibody |
06/28/2007 | US20070148160 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
06/28/2007 | US20070148157 Chondroitinase ABC I polynucleotides |
06/28/2007 | US20070148156 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof |
06/28/2007 | US20070148143 Human cytokine receptor |
06/28/2007 | US20070148089 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
06/28/2007 | DE102005060813A1 Selektive Markierung der Glykane von Antikörpern mit modifizierten Nukleotidzuckern als Substrate von rekombinanten Galactosyltransferasen Selective labeling of glycans of antibodies with modified nucleotide sugars as substrates of recombinant galactosyltransferases |
06/28/2007 | CA2634495A1 Process for the production of preformed conjugates of albumin and a therapeutic agent |
06/28/2007 | CA2634116A1 Anti-ilt7 antibody |
06/28/2007 | CA2633138A1 Methods for generating and screening fusion protein libraries and uses thereof |
06/28/2007 | CA2632435A1 Soluble il-17rc variant and uses thereof |
06/27/2007 | EP1801208A1 Anti-a33 antibody |
06/27/2007 | EP1801204A1 Recombinant herpesvirus of turkeys and uses thereof |
06/27/2007 | EP1801118A1 Process for synthesis of mucin-type peptides and muc1-related glycopeptides |
06/27/2007 | EP1799840A2 Ilt3 polypeptides and uses thereof |
06/27/2007 | EP1799839A2 Increasing the stability of recombinant adult human apohemoglobin |
06/27/2007 | EP1799838A2 Bioactive compositions, natural methods of producing them and computational methods for designing natural production processes |
06/27/2007 | EP1799234A2 Enhancing recombinant hemoglobin production by co-expression with alpha hemoglobin stabilizing protein |
06/27/2007 | EP1385943B1 Novel alkaline protease variants and detergents and cleaning agents containing said novel alkaline protease variants |
06/27/2007 | EP1355936B1 Polymer conjugates of neublastin and methods of using same |
06/27/2007 | EP1305419B1 Modulation by il-tif/interleukin-21 |
06/27/2007 | EP1220923B1 FACTOR IX/FACTOR IXa ACTIVATING ANTIBODIES |
06/27/2007 | EP1218519B1 Enzyme which cleaves ester groups and which is derived from thermomonospora fusca |
06/27/2007 | EP1110086B1 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
06/27/2007 | CN1989250A Tc-83-derived alphavirus vectors, particles and methods |
06/27/2007 | CN1986829A Preparing process for mannose protein |
06/27/2007 | CN1986828A Fish scale collagen and its production process |
06/27/2007 | CN1986814A Fusion expressed product of vascular inhibine and endostatin in colibacillus and its preparing method |
06/27/2007 | CN1985852A Process of extracting sea cucumber polyose and other active components from boiled sea cucumber juice |
06/27/2007 | CN1323164C Protein complex, process for producing the same and use thereof |
06/26/2007 | US7236891 Methods of determining polypeptide structure and function |
06/26/2007 | US7235709 Transgenic animals with increased slow-twitch muscle fibers and methods of using such animals |
06/26/2007 | US7235652 Transcription activation module comprising nucleotide sequence; vectors for genetic engineering in plants |
06/26/2007 | US7235640 Isolated antibodies to a secretory membrane protein |
06/26/2007 | US7235637 IL-1 eta DNA and polypeptides |
06/26/2007 | US7235633 Cytokine receptors and nucleic acids encoding the same |
06/26/2007 | US7235632 for diagnosing malignant and benign hemopathies; isolated human cell surface protein wherein said protein; expressed at the surface of human lymphoid progenitor cells and mature NK cells |
06/26/2007 | US7235531 Tachykinin-like polypeptides and use thereof |
06/26/2007 | US7235529 Brain-associated inhibitor of tissue-type plasminogen activator |
06/26/2007 | US7235401 Expression vector which comprises live reporter molecule sequence unregulatory control of cell cycle phase-specific expression elements for use in continous monitoring of cell cycle progression |
06/26/2007 | US7235394 Relates to determination of functional HCV virus genomic RNA sequences, construction of infectious HCV DNA clones, and to use of the clones or their derivatives in therapeutic, vaccine, and diagnostic applications |
06/26/2007 | US7235386 Method of increasing complementarity in a heteroduplex |
06/26/2007 | US7235385 Methods for enhancing expression of recombinant proteins |
06/26/2007 | US7235383 Drug screening by contacting interacting domain of presenilin protein with presenilin-binding protein in presence of test subject and measuring interaction of proteins |
06/26/2007 | US7235382 Cell extract from the germ of flowering plants for cell-free protein synthesis, wherein a ribosome deadenylation ratio of the cell extract is 1% or lower; means for cell-free protein synthesis improved in productivity, yield, and simplicity |
06/26/2007 | US7235381 Expressed sequence tags and encoded human proteins |
06/26/2007 | US7235380 CDR-grafted anti-tissue factor antibodies and methods of use thereof |
06/26/2007 | US7235374 Systems for sensitive detection of G-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
06/26/2007 | US7235372 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
06/26/2007 | US7235371 Human osteoclast derived cathepsin |
06/26/2007 | US7235366 Methods of identifying agonists and antagonists of opioid receptors |
06/26/2007 | US7235362 Compositions and methods for protein isolation |
06/26/2007 | US7235243 Immunological combination compositions and methods |
06/26/2007 | US7235241 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
06/26/2007 | US7235238 Antibodies that bind receptor protein designated 2F1 |
06/26/2007 | US7235232 Interferon alpha hybrids |
06/26/2007 | CA2265464C Therapy for .alpha.-galactosidase a deficiency |
06/26/2007 | CA2216827C Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein |
06/26/2007 | CA2186423C Protein which induces interferon-gamma production by immunocompetent cell |
06/26/2007 | CA2176215C Stable cell lines capable of expressing the adeno-associated virus replication gene |
06/26/2007 | CA2157118C Isolation of components of interest from milk |
06/26/2007 | CA2154445C Lysosomal targeting of immunogens |
06/26/2007 | CA2139862C Use of p97 and iron binding proteins as diagnostic and therapeutic agents |
06/26/2007 | CA2065797C Monoclonal antibody, polypeptide and production thereof |
06/21/2007 | WO2007070659A2 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
06/21/2007 | WO2007070315A2 Improved production of glycoproteins using manganese |
06/21/2007 | WO2007069604A1 Method for production of modified protein |
06/21/2007 | WO2007068163A1 Hiv fusion inhibitor peptides and use thereof |
06/21/2007 | WO2007068105A1 Method of diagnosing amyotrophic lateral sclerosis |
06/21/2007 | WO2007024877A3 Compositions and methods for analyzing protein interactions |
06/21/2007 | WO2006101782A3 A cysteine-containing peptide tag for site-specific conjugation of proteins |
06/21/2007 | WO2006063336A3 Thermostable omega-transaminases |
06/21/2007 | WO2006047242A8 Duffy antigen receptor for chemokines and use thereof |
06/21/2007 | US20070143871 Non-human transgenic animal models for hepatocellular carcinoma |
06/21/2007 | US20070142627 Sugar-chain-altered anti-hm1.24 antibody |
06/21/2007 | US20070142624 Purifying lectin Concanavalin A (Con A) using a buffer in which impurities, such as glycogen and other substances are soluble, but in which the protein remains insoluble |
06/21/2007 | US20070142623 Protein expression system |
06/21/2007 | US20070142312 Antigen delivery system |
06/21/2007 | US20070142295 Thrombopoietic compounds |
06/21/2007 | US20070142294 Identification and cloning of novel human gene, RET16, involved in the intracellular signaling cascade |
06/21/2007 | US20070142292 Stimulates production of macrophage inflammatory protein from hepatocytes; metal chelator; inhibits bacterial growth |
06/21/2007 | US20070142288 Isolated MCPIP and methods of use |
06/21/2007 | US20070142284 Vascular endothelial cell growth factor variants and uses thereof |
06/21/2007 | US20070142282 Modified VEGF-A with improved angiogenic properties |
06/21/2007 | US20070142280 Factor VII or VIIa-like molecules |
06/21/2007 | US20070142277 Bace455, an alternative splice variant of the human beta-secretase |
06/21/2007 | US20070142275 for the treatment of diseases and pathological alterations associated with excessive or deregulated TGF- beta 1 expression |
06/21/2007 | US20070142274 Fish protein hydrolyzate |